The DOI matches its Crossref record, with a small difference in title or year; 32 of the 32 references it cites were found in a registry or an index.
Novel Approaches for Preventing or Limiting Events (Naples) II Trial
Open accessAbstract
Objectives Atorvastatin administered at least 7 days before the percutaneous coronary intervention (PCI) reduces the rate of periprocedural myocardial infarction (MI). It is unknown whether a single, high (80 mg) loading dose of atorvastatin may reduce the rate of periprocedural MI.Background Periprocedural MI is a prognostically important complication of PCI.Methods The day before the elective PCI, 668 statin-naive patients were randomly assigned to atorvastatin 80 mg (atorvastatin group; n = 338) or no statin treatment (control group; n = 330). Creatine kinase-myocardial isoenzyme (CK-MB) (upper limit of normal [ULN] 3.5 ng/ml) and cardiac troponin I (ULN 0.10 ng/ml) were assessed before and 6 and 12 h after the intervention. Periprocedural MI was defined as a CK-MB elevation >3x ULN alone or associated with chest pain or ST-segment or T-wave abnormalities.Results The incidence of a periprocedural MI was 9.5% in the atorvastatin group and 15.8% in the control group (odds ratio: 0.56; 95% confidence interval: 0.35 to 0.89; p = 0.014). Median CK-MB peak after PCI was 2.10 ng/ml (interquartile range 1.00 to 12.50 ng/ml) in the atorvastatin group and 3.20 ng/ml (interquartile range 1.37 to 16.07 ng/ml) in the control group (p = 0.014). The incidence of cardiac troponin I elevation >3x ULN was 26.6% in the atorvastatin group and 39.1% in the control group (odds ratio: 0.56; 95% confidence interval: 0.40 to 0.78; p < 0.001).Conclusions A single, high (80 mg) loading (within 24 h) dose of atorvastatin reduces the incidence of periprocedural MI in elective PCI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ideally, patients should be signed up to cardiac rehabilitation programmes to enhance the control of lipid levels [434] and improve overall survival following ACS [435].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [435]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide: an endogenous modulator of leukocyte adhesion.
Kubes, P., Suzuki, M., & Granger, D. N. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4651 · Cited by 3,036
Task Force Members, Thygesen, K. A., Alpert, J. S., White, H. D., Biomarker Group, Jaffe, A. S., Apple, F. S., Galvani, M., Katus, H. A., Newby, L. K., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm355 · Cited by 2,536
Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors
Laufs, U., Fata, V. L., Plutzky, J., & Liao, J. K. (1998) · Circulation · doi:10.1161/01.cir.97.12.1129 · Cited by 1,837
Beneficial Cardiovascular Pleiotropic Effects of Statins
Davignon, J. (2004) · Circulation · doi:10.1161/01.cir.0000131517.20177.5a · Cited by 955
Antiatherothrombotic Properties of Statins
Rosenson, R. S., & Tangney, C. (1998) · JAMA · doi:10.1001/jama.279.20.1643 · Cited by 954
UNIVERSAL DEFINITION OF MYOCARDIAL INFARCTION
Thygesen, K. A., Alpert, J. S., & White, H. D. (2008) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2008-4-5-91-105 · Cited by 527
Randomized Trial of Atorvastatin for Reduction of Myocardial Damage During Coronary Intervention
Pasceri, V., Patti, G., Nusca, A., Pristipino, C., Richichi, G., & Sciascio, G. D. (2004) · Circulation · doi:10.1161/01.cir.0000137828.06205.87 · Cited by 466
Simvastatin Preserves the Ischemic-Reperfused Myocardium in Normocholesterolemic Rat Hearts
Lefer, A. M., Campbell, B., Shin, Y.-K., Scalia, R. G., Hayward, R., & Lefer, D. J. (1999) · Circulation · doi:10.1161/01.cir.100.2.178 · Cited by 327
Peri-procedural myocardial injury: 2005 update
Herrmann, J. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi455 · Cited by 324
Di Sciascio, G., Patti, G., Pasceri, V., Gaspardone, A., Colonna, G., & Montinaro, A. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.05.028 · Cited by 315
Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect
Inoue, I., Goto, S.-I., Mizotani, K., Awata, T., Mastunaga, T., Kawai, S.-I., Nakajima, T., Hokari, S., Komoda, T., & Katayama, S. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00680-9 · Cited by 298
Inhibition of Monocyte Chemotactic Protein-1 Synthesis by Statins
Romano, M., Diomede, L., Sironi, M., Massimiliano, L., Sottocorno, M., Polentarutti, N., Guglielmotti, A., Albani, D., Bruno, A., Fruscella, P., et al. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780115 · Cited by 296
Prognostic Implication of Creatine Kinase Elevation Following Elective Coronary Artery Interventions
Kong, T. Q. (1997) · JAMA · doi:10.1001/jama.1997.03540300029029 · Cited by 280
Bell, R. M., & Yellon, D. M. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02816-4 · Cited by 261
Notarbartolo, A., Davı̀, G., Averna, M. R., Barbagallo, C. M., Ganci, A., Giammarresi, C., Placa, F. L., & Patrono, C. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.2.247 · Cited by 259
Bourcier, T., & Libby, P. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.2.556 · Cited by 233
Death Following Creatine Kinase-MB Elevation After Coronary Intervention
Ellis, S. G., Chew, D. P., Chan, A. W., Whitlow, P. L., Schneider, J. P., & Topol, E. J. (2002) · Circulation · doi:10.1161/01.cir.0000028146.71416.2e · Cited by 209
Cavallini, C., Savonitto, S., Violini, R., Arraiz, G., Plebani, M., Olivari, Z., Rubartelli, P., Battaglia, S., Niccoli, L., Steffenino, G., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi173 · Cited by 203
Briguori, C., Colombo, A., Airoldi, F., VIOLANTE, A., Focaccio, A., BALESTRIERI, P., PAOLOELIA, P., Golia, B., LEPORE, S., & Riviezzo, G. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.07.017 · Cited by 175
Self-citationStatin Therapy in Acute Coronary Syndromes
Sposito, A. C., & Chapman, M. J. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000032033.39301.6a · Cited by 157
Ueda, Y., Kitakaze, M., Komamura, K., Minamino, T., Asanuma, H., Sato, H., Kuzuya, T., Takeda, H., & Hori, M. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00440-4 · Cited by 116
Hussein, O., Rosenblat, M., Schlezinger, S., Keidar, S., & Michael, A. (1997) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1997.00625.x · Cited by 105
Pravastatin: An Antithrombotic Effect Independent of the Cholesterol-lowering Effect
Smith, D., Unger, A., Shao, J., Meraj, P., Fier, C., Cohen, A., Fallon, J., Badimon, J., Ambrose, J., & Dangas, G. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613893 · Cited by 103
Steinhubl, S. R., Lauer, M. S., Mukherjee, D., Moliterno, D. J., Lincoff, A. M., Ellis, S. G., & Topol, E. J. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00376-3 · Cited by 81
Platelet Cytosolic Ca 2+ and Membrane Dynamics in Patients With Primary Hypercholesterolemia
Sang, K. L. Q., Levenson, J. A., Mégnien, J. L., Simon, A. C., & Devynck, M. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.6.759 · Cited by 77
Blankenship, J. C., Tasissa, G., O’Shea, J. C., Iliadis, E. A., Bachour, F. A., Cohen, D. J., Lui, H. K., Mann, T., Cohen, E. A., & Tcheng, J. E. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01423-1 · Cited by 54
Merla, R., Reddy, N. K., Wang, F.-W., Uretsky, B. F., Barbagelata, A., & Birnbaum, Y. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.03.105 · Cited by 40
Ellis, S. G., Brener, S. J., Lincoff, A. M., Moliterno, D. J., Whitlow, P. L., Schneider, J. P., & Topol, E. J. (2001) · Circulation · doi:10.1161/hc4701.099782 · Cited by 34
Ošťádal, P., Alan, D., Hájek, P., Horak, D., Vejvoda, J., Trefanec, J., Mates, M., & Vojáček, J. (2003) · Springer eBooks · doi:10.1007/978-1-4615-0298-2_7 · Cited by 33
Veselka, J., Procházková, Š., Duchoňová, R., Homolová, I., Tesař, D., & Bybee, K. A. (2006) · Heart and Vessels · doi:10.1007/s00380-005-0885-x · Cited by 28
Ošťádal, P., Alan, D., Hajek, P., Horak, D., Vejvoda, J., Trefanec, J., Mates, M., & Vojacek, J. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1023499727477 · Cited by 20
Briguori, C., Colombo, A., & Airoldi, F. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.12.105 · Cited by 9
Self-citation
Cited by
Sorted by citations
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
Levine, G. N., Bates, E., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., Hollenberg, S. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31823ba622 · Cited by 3,305
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw272 · Cited by 3,162
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
Levine, G. N., Bates, E., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., Hollenberg, S. M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.007 · Cited by 2,182
Metadata
- Authors
- Briguori, C., Visconti, G., Focaccio, A., Golia, B., Chieffo, A., Castelli, A., Mussardo, M., Montorfano, M., Ricciardelli, B., & Colombo, A.
- Affiliations
- Vita-Salute San Raffaele University (IT)
- Clinica Mediterranea (IT)
- Corresponding author
- Briguori, Carlo
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2009-12
- Volume
- 54
- Issue
- 23
- Pages
- 2157-2163
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W71404102
- Cited by
- 238
- References
- 32
- Citations by year
- 2025: 2 · 2024: 6 · 2023: 3 · 2022: 7 · 2021: 5 · 2020: 6 · 2019: 10 · 2018: 7 · 2017: 8 · 2016: 16 · 2015: 20 · 2014: 14 · 2013: 25 · 2012: 26
- FWCI
- 36.84
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Keywords
- atorvastatin, periprocedural myocardial infarction, percutaneous coronary intervention, statin-naive patients, CK-MB, cardiac troponin I, ST segment abnormalities, T wave changes
- MeSH terms
- Atorvastatin, Aged, Dose-Response Relationship, Drug, Electrocardiography, Female, Heptanoic Acids, Humans, Male, Middle Aged, Myocardial Infarction, Pyrroles, Myocardial Reperfusion Injury, Angioplasty, Balloon, Coronary, Treatment Outcome, Hydroxymethylglutaryl-CoA Reductase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
